NewGenIvf Group Limited (NIVF) 주식 분석

회사 개요

NewGenIvf Group Limited operates primarily as an investment holding company dedicated to delivering assisted reproductive services, specifically facilitating fertility treatments for couples and individuals across Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The firm functions within the healthcare sector, more specifically categorized under the medical care facilities industry, which implies a focus on specialized clinical operations and patient care infrastructure rather than broad pharmaceutical manufacturing. This company currently maintains a market capitalization of $1.21M and generates annual revenue of $4.73M, though the precise number of employees is not disclosed in available financial records. The combination of a market cap under $1.3M and revenue of approximately $4.73M indicates that the company functions as a micro-cap entity, suggesting a niche operational scope and a relatively small market presence within the global fertility treatment landscape.

재무 건전성

The company reports a trailing twelve-month revenue of $4.73M alongside a net income of $9.88M, while reporting an EBITDA of $-10,538,352, a divergence that highlights significant non-cash adjustments or accounting differences between operating earnings and net profit. This substantial gap between the reported revenue and net income, contrasted with the negative EBITDA, reveals a complex cost structure where operating expenses before depreciation and amortization exceed operating revenue, yet the final accounting profit remains positive due to specific financial instrument treatments or tax effects. The free cash flow stands at $-11,179,275, indicating that the company is currently consuming more cash than it generates from operations, which limits its immediate financial flexibility for capital expenditures or acquisitions without external financing. Margin analysis shows a gross margin of 20.2%, an operating margin of -349.1%, and a profit margin of 209.0%, illustrating a scenario where core operating activities are unprofitable at scale while the bottom line is inflated, likely by non-operating income or one-time gains. On the balance sheet, the company holds $1.30M in cash against total debt of $4.87M, resulting in a debt-to-equity ratio of 18.74, which suggests a highly leveraged capital structure given the small equity base. However, the current ratio of 3.12 indicates strong short-term liquidity, meaning the company possesses more than three times the current assets required to meet its short-term obligations. Return on Equity is calculated at 79.4%, while Return on Assets is -36.9%, metrics that collectively reveal a management effectiveness profile where equity is being leveraged heavily to generate profits, but the asset base as a whole is not covering its costs efficiently on an accrual basis.

밸류에이션 평가

The valuation metrics display a stark contrast between the trailing P/E ratio of 0.06 and the forward P/E of 0.23, implying that the market expects earnings growth in the future that would significantly alter the current valuation multiple, although the low trailing figure suggests current earnings are exceptionally high relative to the stock price. The price-to-book ratio is listed as 0.00, which indicates that the market is valuing the company at less than its book value per share, a common characteristic for micro-cap firms with significant intangible assets or specific accounting classifications that do not reflect on the balance sheet. The price-to-sales ratio stands at 0.26, while the EV/EBITDA is unavailable due to the negative EBITDA figure, suggesting that traditional enterprise value multiples are not applicable and that valuation must rely on revenue-based or equity-based metrics instead. The 52-week high is recorded at $1839.00 and the low at $1.52, meaning the current trading price sits extremely close to the lower bound of its historical range, specifically trading at a percentage significantly below the 52-week high. The beta value is not available, preventing a direct assessment of price volatility relative to the broader market, but the wide spread between the 52-week high and low suggests inherent volatility often found in low-priced stocks.

Growth & Income

Revenue growth year-over-year is recorded at 11.9%, whereas earnings growth is not available due to the unique accounting profile or lack of comparable prior period data for growth calculations. Since earnings growth cannot be directly compared to revenue growth with precise figures, the implication is that the high profit margin is being maintained or expanded as revenue grows, rather than earnings lagging behind sales. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm reinvests all available net income back into the business operations or retains them to strengthen the balance sheet rather than distributing them to shareholders. Consequently, the overall growth and income profile is characterized by strong top-line expansion and high profitability retention, with no reliance on dividend income for investors.